Total Payments
$244,252
2024 Payments
$60,357
Companies
6
Transactions
254
Medicare Patients
2,179
Medicare Billing
$153,168
Payment Breakdown by Category
Other$181,114 (74.2%)
Travel$40,706 (16.7%)
Consulting$16,873 (6.9%)
Food & Beverage$5,553 (2.3%)
Education$6.88 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $181,114 | 64 | 74.2% |
| Travel and Lodging | $40,706 | 94 | 16.7% |
| Consulting Fee | $16,873 | 7 | 6.9% |
| Food and Beverage | $5,553 | 88 | 2.3% |
| Education | $6.88 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $223,316 | 226 | $0 (2024) |
| Harmony Biosciences LLC | $20,598 | 22 | $0 (2023) |
| Eisai Inc. | $125.00 | 1 | $0 (2019) |
| ZOLL Respicardia, Inc. | $125.00 | 1 | $0 (2024) |
| Resmed Corp | $50.23 | 3 | $0 (2022) |
| Inspire Medical Systems, Inc. | $36.77 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60,357 | 51 | JAZZ PHARMACEUTICALS INC. ($60,195) |
| 2023 | $68,411 | 63 | JAZZ PHARMACEUTICALS INC. ($59,204) |
| 2022 | $50,008 | 58 | JAZZ PHARMACEUTICALS INC. ($40,417) |
| 2021 | $7,612 | 11 | JAZZ PHARMACEUTICALS INC. ($5,771) |
| 2020 | $7,691 | 12 | Jazz Pharmaceuticals Inc. ($7,691) |
| 2019 | $14,490 | 20 | JAZZ PHARMACEUTICALS INC. ($14,365) |
| 2018 | $24,811 | 27 | Jazz Pharmaceuticals Inc. ($24,800) |
| 2017 | $10,873 | 12 | Jazz Pharmaceuticals Inc. ($10,873) |
All Payment Transactions
254 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $168.00 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $142.78 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,610.00 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $102.62 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $14.00 | General |
| Category: NEUROLOGY | ||||||
| 10/14/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,590.00 | General |
| Category: NEUROLOGY | ||||||
| 10/04/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $641.96 | General |
| Category: NEUROLOGY | ||||||
| 09/26/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $275.14 | General |
| Category: NEUROLOGY | ||||||
| 09/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $102.18 | General |
| Category: NEUROLOGY | ||||||
| 09/06/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $671.96 | General |
| Category: NEUROLOGY | ||||||
| 07/15/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $172.86 | General |
| Category: NEUROLOGY | ||||||
| 07/15/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $112.69 | General |
| Category: NEUROLOGY | ||||||
| 06/26/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,610.00 | General |
| Category: NEUROLOGY | ||||||
| 06/22/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $222.08 | General |
| Category: NEUROLOGY | ||||||
| 06/22/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $112.21 | General |
| Category: NEUROLOGY | ||||||
| 06/17/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,530.00 | General |
| Category: NEUROLOGY | ||||||
| 06/13/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $578.96 | General |
| Category: NEUROLOGY | ||||||
| 05/01/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,610.00 | General |
| Category: NEUROLOGY | ||||||
| 04/27/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $279.01 | General |
| Category: NEUROLOGY | ||||||
| 04/26/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $72.33 | General |
| Category: NEUROLOGY | ||||||
| 04/10/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Travel and Lodging | In-kind items and services | $411.38 | General |
| Category: NEUROLOGY | ||||||
| 04/08/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,610.00 | General |
| Category: NEUROLOGY | ||||||
| 04/03/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $382.50 | General |
| Category: NEUROLOGY | ||||||
| 04/03/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $123.00 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 549 | 575 | $123,076 | $43,664 |
| 2022 | 7 | 459 | 474 | $82,042 | $34,951 |
| 2021 | 10 | 633 | 674 | $122,109 | $43,525 |
| 2020 | 9 | 538 | 564 | $103,324 | $31,027 |
Total Patients
2,179
Total Services
2,287
Medicare Billing
$153,168
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 97 | $19,829 | $8,412 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 122 | $17,488 | $7,136 | 40.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 57 | $16,068 | $6,883 | 42.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 49 | 51 | $14,443 | $4,711 | 32.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 55 | 55 | $21,120 | $4,595 | 21.8% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 115 | 115 | $15,707 | $3,581 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $7,430 | $3,427 | 46.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $6,986 | $3,179 | 45.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,685 | $1,187 | 44.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 15 | $1,320 | $553.93 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 63 | $11,139 | $6,050 | 54.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 42 | $10,374 | $5,781 | 55.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 76 | $9,400 | $4,851 | 51.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 50 | 50 | $13,268 | $4,559 | 34.4% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 121 | 121 | $14,285 | $3,898 | 27.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 23 | 23 | $5,336 | $2,441 | 45.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $4,616 | $2,170 | 47.0% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 20 | 20 | $4,947 | $1,917 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 26 | 27 | $4,617 | $1,687 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 35 | 35 | $4,060 | $1,598 | 39.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 104 | 119 | $20,349 | $8,146 | 40.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 57 | 67 | $15,544 | $7,330 | 47.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 118 | 132 | $15,312 | $6,063 | 39.6% |
| 95806 | Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | Facility | 2021 | 184 | 184 | $24,104 | $5,925 | 24.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 32 | 32 | $10,592 | $4,303 | 40.6% |
About Dr. Kirk Watkins, MD
Dr. Kirk Watkins, MD is a Sleep Medicine healthcare provider based in St George, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1326220559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kirk Watkins, MD has received a total of $244,252 in payments from pharmaceutical and medical device companies, with $60,357 received in 2024. These payments were reported across 254 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($181,114).
As a Medicare-enrolled provider, Watkins has provided services to 2,179 Medicare beneficiaries, totaling 2,287 services with total Medicare billing of $153,168. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Location St George, UT
- Active Since 11/29/2007
- Last Updated 01/22/2016
- Taxonomy Code 207QS1201X
- Entity Type Individual
- NPI Number 1326220559
Products in Payments
- XYWAV (Drug) $165,429
- Xyrem (Drug) $35,674
- XYREM (Drug) $19,204
- Wakix (Drug) $11,392
- WAKIX (Drug) $9,206
- remede System (Device) $125.00
- INSPIRE (Device) $36.77
- AIR 11 (Device) $27.44
- AirSense (Device) $22.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.